BioSpace News Archive

SciSparc Ltd. Announces Closing of $10 Million Private Placement Priced At-the-Market

SciSparc Ltd. closed its previously announced private placement pursuant to a securities purchase agreement with a single healthcare-focused institutional investor for gross proceeds of approximately $10 million, before deducting fees to the placement agent and other expenses payable by the Company.

June 1, 2022
·
2 min read
Biotech Bay

Jazz Pharmaceuticals to Participate in the Jefferies Healthcare Conference - June 01, 2022

Jazz Pharmaceuticals plc announced that the Company will participate in the Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 11:00 a.m. PT / 2:00 p.m. ET / 7:00 p.m. IST in New York.

June 1, 2022
·
1 min read
Business

Repare Therapeutics Announces a Worldwide License and Collaboration Agreement with Roche for Camonsertib (RP-3500)

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), today announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib (also known as RP-3500).

June 1, 2022
·
7 min read
HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), announced that it will be hosting a scientific webinar titled “Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research” on June 23, 2022.

June 1, 2022
·
1 min read
Genetown

TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 01, 2022

TCR2 Therapeutics Inc. announced that on May 31, 2022, the Compensation Committee of the Board of Directors of TCR2’s approved the grant of inducement stock options covering an aggregate of 19,800 shares of TCR2’s common stock to 3 new non-executive employees.

June 1, 2022
·
2 min read
FDA

FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has approved the use of Nyxoah’s next generation Genio® 2.1 system for use in the Company’s DREAM U.S. IDE pivotal study.

June 1, 2022
·
3 min read
Bio NC

Chimerix to Present at Jefferies Global Healthcare Conference - June 01, 2022

Chimerix announced that Mike Sherman, Chief Executive Officer, will present a corporate overview at the upcoming Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 3:30 p.m. in New York City.

June 1, 2022
·
1 min read
Genetown

Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference - June 01, 2022

Gamida Cell Ltd. announces that company management will present its corporate highlights at the Jefferies Healthcare Conference, June 8, 2022 with a presentation at 11:00 a.m. ET in New York, NY.

June 1, 2022
·
7 min read
Biotech Bay

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - June 01, 2022

Sangamo Therapeutics, Inc., a genomic medicine company, announced that management will be participating in the following investor conferences:

June 1, 2022
·
1 min read
Biotech Bay

Agilent to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Agilent Technologies Inc. announced the company will participate in the Goldman Sachs 43rd Annual Healthcare Conference on Wednesday, June 15, in Rancho Palos Verdes, California.

June 1, 2022
·
1 min read